Full-Time

Wealth – WCM Portfolio Strategy Officer

VP

Posted on 12/20/2024

Citigroup

Citigroup

10,001+ employees

Global financial services and banking solutions

Compensation Overview

$129.8k - $194.8k/yr

+ Incentive Awards + Retention Awards

Senior

New York, NY, USA

Category
Risk Management
Finance & Banking
Required Skills
Python
Risk Management
Data Analysis
Requirements
  • Relevant professional experience performing similar tasks in a Market Risk or Counterparty Risk Management function
  • Strong quantitative skills, particularly with respect to counterparty risk stress testing and exposure valuations
  • Working knowledge of securities financing transactions and derivative products
  • Excellent analytical background and skill set to understand complex processes, including system data flows
  • Working knowledge of a programming language, preferably Python
  • Excellent people skills: ability to interact successfully with business partners and technology teams
Responsibilities
  • Support monitoring and management of Counterparty Credit Risk including the development and automation of risk management reports and associated controls
  • Undertake portfolio risk reviews for internal stakeholders ensuring high quality and timely information is provided to enable proactive risk management
  • Analyse the sources of counterparty risk in Wealth portfolio, with particular focus on stress testing, early warning indicators, collateral risk and volatility, concentration risks, liquidity and wrong way risk
  • From a portfolio management perspective, ability to set-up and follow-up on actions that reduce process issues and enhance integrity of the risk management data
  • Partner with the established CCR functions of Citigroup to align and streamline CCR risk management processes, risk measures, systems, data and reporting for Wealth portfolio risks
Desired Qualifications
  • Post-graduate education in Finance, Financial Risk Management, or other quantitative discipline preferred

Citigroup provides a variety of financial services to individuals, businesses, and governments around the world. Its offerings include consumer banking, credit, corporate and investment banking, securities brokerage, and wealth management. The company operates in over 160 countries, allowing it to facilitate cross-border transactions and serve a diverse clientele. Citigroup's products work by leveraging its extensive global network and technology to provide efficient banking solutions, generating revenue through interest on loans, service fees, trading, and investment management. What sets Citigroup apart from its competitors is its strong focus on sustainability and social responsibility, as demonstrated by its investments in environmental, social, and governance (ESG) initiatives. The company's goal is to create a positive financial and social impact while achieving growth and profitability.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1812

Simplify Jobs

Simplify's Take

What believers are saying

  • Citi's leadership in debt syndication strengthens its position in corporate banking.
  • Investments in AI and machine learning enhance risk management and fraud detection capabilities.
  • Partnerships with fintechs like Validis modernize business lending and improve decision-making.

What critics are saying

  • Competition from fintechs like Nammu21 threatens Citi's traditional banking services.
  • Alternative funding platforms like Capital on Tap may divert clients from Citi.
  • Rapid growth of DeFi platforms challenges traditional banking models, requiring adaptation.

What makes Citigroup unique

  • Citi's global presence in over 160 countries sets it apart from competitors.
  • Strong focus on ESG initiatives enhances Citi's reputation and attracts socially conscious investors.
  • Technological innovation in digital banking solutions boosts customer engagement and satisfaction.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Wellness Program

Paid Vacation

Paid Sick Leave

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-5%

2 year growth

-5%
Finance Director Europe
Mar 18th, 2025
Nammu21 announces strategic investments from Nasdaq Ventures, State Street, and UBS

With fully automated technology, Nammu21 streamlines loan operations, improves productivity by eliminating the inefficiencies of manual inputs across legacy operating systems

The Asset
Feb 27th, 2025
Citigroup leads US$850 million debt syndicate for Danaos

New York-listed Danaos Corporation has signed a syndicated loan amounting to US$850 million for the financing of 14 containerships being built in Chinese yards.

FF News
Feb 20th, 2025
Capital on Tap Secures £750 Million in Landmark Funding Facilities to Accelerate Small Business Growth

Capital on Tap has secured major funding facilities for its card totalling £750 million to fuel expansion and support for small businesses

FF News
Feb 11th, 2025
Proxymity Secures $26M Funding Boost

Proxymity has secured $26 million in additional growth funding from existing investors, including BNP Paribas, BNY, Citi, Clearstream, Computershare, J.P. Morgan, and State Street. This funding supports Proxymity's innovative technology in proxy voting and shareholder communications. The capital will enhance technology and support geographic expansion. Investors express confidence in Proxymity's potential and its impact on transparency and efficiency in investor communications.

Capital Riesgo
Jan 22nd, 2025
Anaconda BioMed secures €3.6M investment

In December, Innvierte, promoted by CDTI Innovación, invested €171 million in 16 co-investments and two investment vehicles. Notably, Anaconda BioMed received a €3.6 million commitment from CDTI Innovación, alongside other investors, to enhance its advanced catheter systems for ischemic stroke treatment. Additionally, CDTI committed €10 million to Oncomatryx Biopharma and €1.734 million to Payload Aerospace.

INACTIVE